CDX2 can increase NK cell migration and cytolytic activity via up‐regulation of CXCL14, and the CDX2/CXCL14 axis inhibits the tumorigenesis of HNSCC in mice through NK cells. Here, CXCL14 is linked to head and neck squamous cell carcinoma.